Headlines: Big Pharma Reboots Tired Tactics During Hill Grilling
Feb 28, 2019
Testimony from Seven Drug Makers Showcases Continued Unwillingness to Take… Read More
© 2024 CSRXP- All Rights Reserved
Blog Posts
They Said It: Senators Slam Big Pharma CEOs For Price Gouging, Anti-Competitive Tactics
Feb 27, 2019
On Tuesday, the U.S. Senate Committee on Finance held its second hearing on… Read More
“DOSE OF REALITY” Recap
Feb 26, 2019
Big Pharma’s True Track Record Is A Hard Pill To Swallow Looking back at Big… Read More
DOSE OF REALITY: Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part VII
Feb 25, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
“DOSE OF REALITY” Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part VI
Feb 22, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
“DOSE OF REALITY” Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part V
Feb 21, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
“DOSE OF REALITY” Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part IV
Feb 20, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
“DOSE OF REALITY” Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part III
Feb 19, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
DOSE OF REALITY: Big Pharma’s True Track Record Is A Hard Pill To Swallow – Part II
Feb 18, 2019
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
DOSE OF REALITY: Big Pharma’s True Track Record Is A Hard Pill To Swallow – Part I
Feb 15, 2019
As bipartisan momentum to hold Big Pharma accountable and take action on… Read More
They Said It! House Lawmakers Agree Bipartisan Action Needed To Bring Down Drug Prices
Feb 13, 2019
On Tuesday, the U.S. House Committee on Ways & Means held the third… Read More
What they’re Saying: Reactions to Congress’ Drug Pricing Hearings
Feb 2, 2019
On Tuesday, the U.S. House Oversight and Reform and Senate Finance Committees… Read More